PTC Therapeutics | PTCT - Passivo Circulante





Passivo Circulante Alterar Data
Acadia Pharmaceuticals USD 361.44M 55.91M 2026-06
Alnylam Pharmaceuticals USD 2.06B 550.49M 2026-09
Amgen USD 25.5B 547M 2026-06
BioCryst Pharmaceuticals USD 208.85M 13.46M 2026-06
Biogen USD 3.9B 18.7M 2026-09
BioMarin Pharmaceutical USD 1.66B 870.84M 2026-06
Cytokinetics USD 181.43M 17.76M 2026-06
Daiichi Sankyo JPY 765.7B 119.32B 2026-06
Enanta Pharmaceuticals USD 44.73M 3.83M 2025-12
Gilead Sciences USD 12B 982M 2026-09
Incyte USD 1.44B 125.72M 2026-09
Ionis Pharmaceuticals USD 315.64M 401.36M 2026-06
Ironwood Pharmaceuticals USD 236.31M 5.91M 2026-03
Karyopharm Therapeutics USD 117.3M 25.24M 2026-03
Novartis USD 31.75B 374M 2026-06
Pfizer USD 32.65B 1.7B 2026-06
PTC Therapeutics USD 776.08M 5.01M 2026-09
Puma Biotechnology USD 82.73M 3.63M 2025-09
Roche Holding CHF 28.85B 846M 2026-06
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Sarepta Therapeutics USD 502.91M 3.74M 2026-06
TG Therapeutics USD 268.49M 81.38M 2026-06
Ultragenyx Pharmaceutical USD 351M 26M 2026-06
Vertex Pharmaceuticals USD 3.94B 57.3M 2026-06
Xencor USD 81.86M 8.41M 2026-06